ID

21873

Descripción

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00415779

Link

https://clinicaltrials.gov/show/NCT00415779

Palabras clave

Versiones (1)
  1. 5/5/17 5/5/17 -
Subido en

5 de mayo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Metastatic Prostate Cancer NCT00415779

Inglés

Eligibility Metastatic Prostate Cancer NCT00415779

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
hormone refractory prostate cancer
Descripción

Hormone refractory prostate cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1328504
stage iv disease with bone metastasis
Descripción

Disease TNM clinical staging | Secondary malignant neoplasm of bone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C3258246
UMLS CUI [2]
C0153690
no immunotherapy, hormonal therapy or radiotherapy within the previous month
Descripción

Immunotherapy Absent | Hormone Therapy Absent | Therapeutic radiology procedure Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0332197
performance status < or = 2 (ecog)
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
serum creatinine < 1.5 mg/100ml
Descripción

Creatinine measurement, serum

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
serum bilirubin < or = 1.25 x unl (upper normal limit) (or < or = 1.5 x unl in the presence of hepatic metastases); sgot e sgpt < or = 1.5 x unl (or < or = 2.5 x unl in presence of hepatic metastases)
Descripción

Serum total bilirubin measurement | Secondary malignant neoplasm of liver | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0494165
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
left ventricular ejection fraction > or = 50% (measured by cardiac ultrasound or muga scan)
Descripción

Left ventricular ejection fraction Cardiac ultrasound | Left ventricular ejection fraction Multiple gated acquisition scanning

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C1655737
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0521317
neutrophils > 1500/mm3; platelets >100000/mm3; hemoglobin >10 g/100 ml· life expectancy of at least 3 months
Descripción

Neutrophil count | Platelet Count measurement | Hemoglobin measurement | Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0200633
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
UMLS CUI [4]
C0023671
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous malignancies with the exception of radically treated epithelioma
Descripción

Malignant Neoplasms | Epithelioma Treated Radical

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0553707
UMLS CUI [2,2]
C1522326
UMLS CUI [2,3]
C0439807
previous chemotherapy
Descripción

Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
comorbidities that would, in the investigator's opinion, contraindicate the use of the drugs in the study
Descripción

Comorbidity | Medical contraindication Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0013230
uncontrolled diabetes
Descripción

Diabetic - poor control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0421258
severe cardiac arrhythmias, severe uncontrolled congestive heart failure, severe ischemic cardiac disease or myocardial infarction within the previous 6 months
Descripción

Cardiac Arrhythmia Severe | Congestive heart failure Uncontrolled Severe | Myocardial Ischemia Severe | Myocardial Infarction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0018802
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C0205082
UMLS CUI [3,1]
C0151744
UMLS CUI [3,2]
C0205082
UMLS CUI [4]
C0027051
severe infection
Descripción

Communicable Disease Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
cerebral metastasis
Descripción

Cerebral metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0555278
pre-existing motor or sensory neurotoxicity > or = grade 2 according to ctc (common toxicity criteria).
Descripción

Neurotoxicity Motor Pre-existing CTCAE Grades | Neurotoxicity Sensory Pre-existing CTCAE Grades

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0235032
UMLS CUI [1,2]
C0501384
UMLS CUI [1,3]
C2347662
UMLS CUI [1,4]
C1516728
UMLS CUI [2,1]
C0235032
UMLS CUI [2,2]
C0501385
UMLS CUI [2,3]
C2347662
UMLS CUI [2,4]
C1516728
Volver a la parte superior de la página

Similar models

Eligibility Metastatic Prostate Cancer NCT00415779

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Hormone refractory prostate cancer
Item
hormone refractory prostate cancer
boolean
C1328504 (UMLS CUI [1])
Disease TNM clinical staging | Secondary malignant neoplasm of bone
Item
stage iv disease with bone metastasis
boolean
C0012634 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0153690 (UMLS CUI [2])
Immunotherapy Absent | Hormone Therapy Absent | Therapeutic radiology procedure Absent
Item
no immunotherapy, hormonal therapy or radiotherapy within the previous month
boolean
C0021083 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
ECOG performance status
Item
performance status < or = 2 (ecog)
boolean
C1520224 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine < 1.5 mg/100ml
boolean
C0201976 (UMLS CUI [1])
Serum total bilirubin measurement | Secondary malignant neoplasm of liver | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
serum bilirubin < or = 1.25 x unl (upper normal limit) (or < or = 1.5 x unl in the presence of hepatic metastases); sgot e sgpt < or = 1.5 x unl (or < or = 2.5 x unl in presence of hepatic metastases)
boolean
C1278039 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
Left ventricular ejection fraction Cardiac ultrasound | Left ventricular ejection fraction Multiple gated acquisition scanning
Item
left ventricular ejection fraction > or = 50% (measured by cardiac ultrasound or muga scan)
boolean
C0428772 (UMLS CUI [1,1])
C1655737 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0521317 (UMLS CUI [2,2])
Neutrophil count | Platelet Count measurement | Hemoglobin measurement | Life Expectancy
Item
neutrophils > 1500/mm3; platelets >100000/mm3; hemoglobin >10 g/100 ml· life expectancy of at least 3 months
boolean
C0200633 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0023671 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Epithelioma Treated Radical
Item
previous malignancies with the exception of radically treated epithelioma
boolean
C0006826 (UMLS CUI [1])
C0553707 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0439807 (UMLS CUI [2,3])
Chemotherapy
Item
previous chemotherapy
boolean
C0392920 (UMLS CUI [1])
Comorbidity | Medical contraindication Investigational New Drugs
Item
comorbidities that would, in the investigator's opinion, contraindicate the use of the drugs in the study
boolean
C0009488 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Diabetic - poor control
Item
uncontrolled diabetes
boolean
C0421258 (UMLS CUI [1])
Cardiac Arrhythmia Severe | Congestive heart failure Uncontrolled Severe | Myocardial Ischemia Severe | Myocardial Infarction
Item
severe cardiac arrhythmias, severe uncontrolled congestive heart failure, severe ischemic cardiac disease or myocardial infarction within the previous 6 months
boolean
C0003811 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018802 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0151744 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
Communicable Disease Severe
Item
severe infection
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Cerebral metastasis
Item
cerebral metastasis
boolean
C0555278 (UMLS CUI [1])
Neurotoxicity Motor Pre-existing CTCAE Grades | Neurotoxicity Sensory Pre-existing CTCAE Grades
Item
pre-existing motor or sensory neurotoxicity > or = grade 2 according to ctc (common toxicity criteria).
boolean
C0235032 (UMLS CUI [1,1])
C0501384 (UMLS CUI [1,2])
C2347662 (UMLS CUI [1,3])
C1516728 (UMLS CUI [1,4])
C0235032 (UMLS CUI [2,1])
C0501385 (UMLS CUI [2,2])
C2347662 (UMLS CUI [2,3])
C1516728 (UMLS CUI [2,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial